Eduardo Castañeda-Saucedo

Dr. Eduardo Castañeda-Saucedo

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MOMonserrat Olea-Flores
Monserrat Olea-Flores
MZMiriam Zuñiga-Eulogio
Miriam Zuñiga-Eulogio
Miguel Mendoza-CatalánMiguel Mendoza-Catalán
Miguel Mendoza-Catalán
HRHugo Alberto Rodríguez Ruiz
Hugo Alberto Rodríguez Ruiz
ECEduardo Castañeda-Saucedo
Eduardo Castañeda-Saucedo
Napoleón Navarro-TitoNapoleón Navarro-Tito
Napoleón Navarro-Tito
Epithelial–mesenchymal transition (EMT) is a reversible cellular process, characterized by changes in gene expression and activation of proteins, favoring the trans-differentiation of the epithelial phenotype to a mesenchymal phenotype. This process increases cell migration and invasion of tumor cells, progression of the cell cycle, and resistance to apoptosis and chemotherapy, all of which support tumor progression. One of the signaling pathways involved in tumor progression is the MAPK pathway. Within this family, the ERK subfamily of proteins is known for its contributions to EMT. The ERK subfamily is divided into typical (ERK 1/2/5), and atypical (ERK 3/4/7/8) members. These kinases are overexpressed and hyperactive in various types of cancer. They regulate diverse cellular processes such as proliferation, migration, metastasis, resistance to chemotherapy, and EMT. In this context, in vitro and in vivo assays, as well as studies in human patients, have shown that ERK favors the expression, function, and subcellular relocalization of various proteins that regulate EMT, thus promoting tumor progression. In this review, we discuss the mechanistic roles of the ERK subfamily members in EMT and tumor progression in diverse biological systems.

1 May 2007 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
Arup IndraArup Indra
Arup Indra
ECEduardo Castañeda-Saucedo
Eduardo Castañeda-Saucedo
MAMaria Cristina Antal
Maria Cristina Antal
MJMing Jiang
Ming Jiang
NMNadia Messaddeq
Nadia Messaddeq
PCPierre Chambon
Pierre Chambon

1 November 2019 in Endocrine Connections
Verified
Journal Article
Open access
PDF file
JJJuan Carlos Juárez-Cruz
Juan Carlos Juárez-Cruz
MZMiriam Zuñiga-Eulogio
Miriam Zuñiga-Eulogio
MOMonserrat Olea-Flores
Monserrat Olea-Flores
ECEduardo Castañeda-Saucedo
Eduardo Castañeda-Saucedo
Miguel Mendoza-CatalánMiguel Mendoza-Catalán
Miguel Mendoza-Catalán
Napoleón Navarro-TitoNapoleón Navarro-Tito
Napoleón Navarro-Tito
Breast cancer is the most common invasive neoplasia, and the second leading cause of the cancer deaths in women worldwide. Mammary tumorigenesis is severely linked to obesity, one potential connection is leptin. Leptin is a hormone secreted by adipocytes, which contributes to the progression of breast cancer. Cell migration, metalloproteases secretion, and invasion are cellular processes associated with various stages of metastasis. These processes are regulated by the kinases FAK and Src. In this study, we utilized the breast cancer cell lines MCF7 and MDA-MB-231 to determine the effect of leptin on FAK and Src kinases activation, cell migration, metalloprotease secretion, and invasion. We found that leptin activates FAK and Src and induces the localization of FAK to the focal adhesions. Interestingly, leptin promotes the activation of FAK through a Src- and STAT3-dependent canonical pathway. Specific inhibitors of FAK, Src and STAT3 showed that the effect exerted by leptin in cell migration in breast cancer cells is dependent on these proteins. Moreover, we established that leptin promotes the secretion of the extracellular matrix remodelers, MMP-2 and MMP-9 and invasion in a FAK and Src-dependent manner. Our findings strongly suggest that leptin promotes the development of a more aggressive invasive phenotype in mammary cancer cells.

1 April 2010 in Current Biology
Verified
Journal Article
Open access
SWSimon A. Woodcock
Simon A. Woodcock
HRHelen J. Rushton
Helen J. Rushton
ECEduardo Castañeda-Saucedo
Eduardo Castañeda-Saucedo
KMKevin Myant
Kevin Myant
GWGavin R.M. White
Gavin R.M. White
AMAngeliki Malliri
Angeliki Malliri
Centrosome separation, critical for bipolar spindle formation and subsequent chromosome segregation during mitosis, occurs via distinct prophase and prometaphase pathways. Kinesin-5 (Eg5), a microtubule (MT) motor, pushes centrosomes apart during bipolar spindle assembly; its suppression results in monopolar spindles and mitotic arrest. Forces that antagonize Eg5 in prophase are unknown. Here we identify a new force generating mechanism mediated by the guanine nucleotide exchange factor (GEF) Tiam1, dependent on its ability to activate the GTPase Rac. We reveal that Tiam1 and Rac localize to centrosomes during prophase and prometaphase, and Tiam1, acting through Rac, ordinarily retards centrosome separation. Importantly, both Tiam1-depleted cells in culture and Rac1-deficient epithelial cells in vivo escape the mitotic arrest induced by Eg5 suppression. Moreover, Tiam1-depleted cells transit more slowly through prometaphase and display increased chromosome congression errors. Significantly, Eg5 suppression in Tiam1-depleted cells rectifies not only their increased centrosome separation but also their chromosome congression errors and mitotic delay. These findings identify Tiam1-Rac signaling as the first antagonist of centrosome separation during prophase, demonstrate its requirement in balancing Eg5-induced forces during bipolar spindle assembly in vitro and in vivo, and show that proper centrosome separation in prophase facilitates subsequent chromosome congression.

16 June 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
HWHelen J. Whalley
Helen J. Whalley
APAndrew P. Porter
Andrew P. Porter
ZDZoi Diamantopoulou
Zoi Diamantopoulou
GWGavin R. M. White
Gavin R. M. White
ECEduardo Castañeda-Saucedo
Eduardo Castañeda-Saucedo
AMAngeliki Malliri
Angeliki Malliri
Centrosome separation is critical for bipolar spindle formation and the accurate segregation of chromosomes during mammalian cell mitosis. Kinesin-5 (Eg5) is a microtubule motor essential for centrosome separation, and Tiam1 and its substrate Rac antagonize Eg5-dependent centrosome separation in early mitosis promoting efficient chromosome congression. Here we identify S1466 of Tiam1 as a novel Cdk1 site whose phosphorylation is required for the mitotic function of Tiam1. We find that this phosphorylation of Tiam1 is required for the activation of group I p21-activated kinases (Paks) on centrosomes in prophase. Further, we show that both Pak1 and Pak2 counteract centrosome separation in a kinase-dependent manner and demonstrate that they act downstream of Tiam1. We also show that depletion of Pak1/2 allows cells to escape monopolar arrest by Eg5 inhibition, highlighting the potential importance of this signalling pathway for the development of Eg5 inhibitors as cancer therapeutics.

1 September 2018 in Cancer Letters
Verified
Journal Article
Closed access
Yarely M. Salinas VeraYarely M. Salinas Vera
Yarely M. Salinas Vera
LMLaurence A Marchat
Laurence A Marchat
RGRaúl García-Vázquez
Raúl García-Vázquez
Claudia Haydée González De La RosaClaudia Haydée González De La Rosa
Claudia Haydée González De La Rosa
ECEduardo Castañeda-Saucedo
Eduardo Castañeda-Saucedo
César López-CamarilloCésar López-Camarillo
César López-Camarillo